Stockreport

Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Upstream Bio, Inc.  (UPB) 
PDF WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an i [Read more]